Filing Details
- Accession Number:
- 0001022079-18-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-31 16:33:27
- Reporting Period:
- 2018-01-29
- Accepted Time:
- 2018-01-31 16:33:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1142624 | H Stephen Rusckowski | 500 Plaza Drive Secaucus NJ 07094 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-29 | 106,840 | $58.18 | 272,956 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-29 | 106,840 | $107.00 | 166,116 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-01-29 | 106,840 | $58.18 | 106,840 | $58.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-05-01 | No | 4 | M | Direct |
Footnotes
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
- The options vested in three equal annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015.